These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 9421486

  • 1. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
    Martin PY, Ohara M, Gines P, Xu DL, St John J, Niederberger M, Schrier RW.
    J Clin Invest; 1998 Jan 01; 101(1):235-42. PubMed ID: 9421486
    [Abstract] [Full Text] [Related]

  • 2. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M, Ginés P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW.
    Hepatology; 1996 Oct 01; 24(4):947-51. PubMed ID: 8855203
    [Abstract] [Full Text] [Related]

  • 3. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis.
    Xu L, Carter EP, Ohara M, Martin PY, Rogachev B, Morris K, Cadnapaphornchai M, Knotek M, Schrier RW.
    Am J Physiol Renal Physiol; 2000 Dec 01; 279(6):F1110-5. PubMed ID: 11097630
    [Abstract] [Full Text] [Related]

  • 4. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC, Fortepiani LA, Martínez-Salgado C, Eleno N, Atucha NM, López-Novoa JM, García-Estañ J.
    Nefrologia; 2001 Dec 01; 21(6):556-64. PubMed ID: 11881425
    [Abstract] [Full Text] [Related]

  • 5. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis.
    Niederberger M, Ginès P, Tsai P, Martin PY, Morris K, Weigert A, McMurtry I, Schrier RW.
    Hepatology; 1995 Jun 01; 21(6):1625-31. PubMed ID: 7768508
    [Abstract] [Full Text] [Related]

  • 6. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM, Carey RM.
    J Clin Invest; 1997 Jul 15; 100(2):264-9. PubMed ID: 9218502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal effects of nitric oxide synthesis inhibition in cirrhotic rats.
    Atucha NM, García-Estañ J, Ramírez A, Pérez MC, Quesada T, Romero JC.
    Am J Physiol; 1994 Dec 15; 267(6 Pt 2):R1454-60. PubMed ID: 7529002
    [Abstract] [Full Text] [Related]

  • 9. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase.
    Arnal JF, Warin L, Michel JB.
    J Clin Invest; 1992 Aug 15; 90(2):647-52. PubMed ID: 1379615
    [Abstract] [Full Text] [Related]

  • 10. The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites.
    Angeli P, Fernández-Varo G, Dalla Libera V, Fasolato S, Galioto A, Arroyo V, Sticca A, Guarda S, Gatta A, Jiménez W.
    Liver Int; 2005 Apr 15; 25(2):429-37. PubMed ID: 15780069
    [Abstract] [Full Text] [Related]

  • 11. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats.
    Weigert AL, Martin PY, Niederberger M, Higa EM, McMurtry IF, Gines P, Schrier RW.
    Hepatology; 1995 Dec 15; 22(6):1856-62. PubMed ID: 7489998
    [Abstract] [Full Text] [Related]

  • 12. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC, Wang SS, Lee FY, Chang CC, Chang FY, Lin HC, Hou MC, Lee SD.
    J Gastroenterol Hepatol; 2008 Jul 15; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N, Vuolteenaho O, Tikkanen I.
    J Renin Angiotensin Aldosterone Syst; 2001 Dec 15; 2(4):233-9. PubMed ID: 11881129
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL, Hon WM, Lee KH, Khoo HE.
    Liver Int; 2005 Jun 15; 25(3):647-56. PubMed ID: 15910502
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.
    Fernández-Varo G, Ros J, Morales-Ruiz M, Cejudo-Martín P, Arroyo V, Solé M, Rivera F, Rodés J, Jiménez W.
    Am J Pathol; 2003 Jun 15; 162(6):1985-93. PubMed ID: 12759254
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats.
    Islas-Carbajal MC, Covarrubias A, Grijalva G, Alvarez-Rodríguez A, Armendáriz-Borunda J, Rincón-Sánchez AR.
    Liver Int; 2005 Feb 15; 25(1):131-40. PubMed ID: 15698410
    [Abstract] [Full Text] [Related]

  • 19. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
    Schwartz D, Schwartz IF, Blantz RC.
    J Lab Clin Med; 2001 Feb 15; 137(2):107-14. PubMed ID: 11174467
    [Abstract] [Full Text] [Related]

  • 20. Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats.
    Wang X, Zhong YX, Zhang ZY, Lu J, Lan M, Miao JY, Guo XG, Shi YQ, Zhao YQ, Ding J, Wu KC, Pan BR, Fan DM.
    World J Gastroenterol; 2002 Apr 15; 8(2):328-32. PubMed ID: 11925618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.